On-Site Genetic Testing for Prostate Cancer Increases Patient Compliance
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3% to 98.7%.
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3% to 98.7%.
Psychiatric comorbidities, chemical restraint use, public insurance tied to emergency revisits; substance use disorders associated with lower likelihood of revisits.
Does not reduce risk of relapse overall, but can reduce relapse risk and manic symptom severity for low-risk individuals.
Hazard of incident diabetes reduced by 44% in adjusted models comparing average daily step count of 10,700 to 6000.
No evidence that large numbers of nurses left health care or hospital practice during first 18 months of pandemic.
Addition of left atrial reservoir strain also yields predicted net benefit in people without prior atrial fibrillation or stroke
Meta-analysis results show the prevalence of obesity among children with type 2 diabetes.
Extended method uses additional data from 1999 to 2016 NHANES, rather than extrapolation; improves characterization of extremely high BMI in children
The percentage of COVID-19 deaths with long COVID peaked in June 2021 and April 2022 at 1.2% and 3.8%
Meta-analysis shows no significant associations between ADHD medication use and cardiovascular disease risk for children, adolescents, or adults or for female patients.